Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Bunionectomy
Public ClinicalTrials.gov record NCT06215820. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Placebo- (Double-Dummy) and Active-Controlled, Parallel-Group Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Bunionectomy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
MR-107A-02 is being studied to investigate its efficacy and safety for treatment of acute pain after bunionectomy.
Study identification
- NCT ID
- NCT06215820
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 410 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 29, 2023 (Actual)
- Primary completion
- Aug 24, 2024 (Actual)
- Completion
- Sep 30, 2024 (Actual)
- Last update posted
- Oct 14, 2025
2023 – 2024
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigator site 114 | Sheffield | Alabama | 35660 | — |
| Investigator site 115 | Phoenix | Arizona | 85053 | — |
| Investigator site 103 | Anaheim | California | 92801 | — |
| Investigator site 110 | Riverside | California | 92501 | — |
| Investigator site 112 | Miami | Florida | 35660 | — |
| Investigator site 108 | Tampa | Florida | 33613 | — |
| Investigator site 109 | Atlanta | Georgia | 30331 | — |
| Investigator site 104 | O'Fallon | Illinois | 62269 | — |
| Investigator site 102 | Pasadena | Maryland | 21122 | — |
| Investigator site 113 | Bellaire | Texas | 77401 | — |
| Investigator site 107 | Carrollton | Texas | 75007 | — |
| Investigator site 106 | Houston | Texas | 77008 | — |
| Investigator site 111 | McAllen | Texas | 78501 | — |
| Investigator site 105 | San Antonio | Texas | 62269 | — |
| Investigator site 101 | Salt Lake City | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06215820, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 14, 2025 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06215820 live on ClinicalTrials.gov.